Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

227 ARTÍCULOS , VIENDO DEL 16 AL 30

Physical modalities in the treatment of neurological dysfunction

Galea MP.

Clin Neurol Neurosurg. 2012 Jun;114(5):483-8. doi: 10.1016/j.clineuro.2012.01.009. Epub 2012 Jan 31.

A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke

Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ; Multicentre Study Group.

Clin Rehabil. 2012 Sep;26(9):787-97. doi: 10.1177/0269215511432016. Epub 2012 Feb 3.

Differential effects of rhythmic auditory stimulation and neurodevelopmental treatment/Bobath on gait patterns in adults with cerebral palsy: a randomized controlled trial

Kim SJ, Kwak EE, Park ES, Cho SR.

Clin Rehabil. 2012 Oct;26(10):904-14. doi: 10.1177/0269215511434648. Epub 2012 Feb 3.

Neurophysiological characterization of the 'new anatomy' and motor control that results from neurological injury or disease

McKay WB.

Clin Neurol Neurosurg. 2012 Jun;114(5):447-54. doi: 10.1016/j.clineuro.2012.01.013. Epub 2012 Feb 5.

The effects of onabotulinum toxin A injection into rectus femoris muscle in hemiplegic stroke patients with stiff-knee gait: a placebo-controlled, nonrandomized trial

Tok F, Balaban B, Yaşar E, Alaca R, Tan AK.

Am J Phys Med Rehabil. 2012 Apr;91(4):321-6. doi: 10.1097/PHM.0b013e3182465feb.

Multiple sclerosis

Nicholas R, Rashid W.

BMJ Clin Evid. 2012 Feb 10;2012:1202.

Non-invasive neuromuscular electrical stimulation in patients with central nervous system lesions: an educational review

Schuhfried O, Crevenna R, Fialka-Moser V, Paternostro-Sluga T.

J Rehabil Med. 2012 Feb;44(2):99-105. doi: 10.2340/16501977-0941.

Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease

Ashworth NL, Satkunam LE, Deforge D.

Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD004156. doi: 10.1002/14651858.CD004156.pub4.

Neurobiological perspective of spasticity as occurs after a spinal cord injury

Roy RR, Edgerton VR.

Exp Neurol. 2012 May;235(1):116-22. doi: 10.1016/j.expneurol.2012.01.017. Epub 2012 Jan 27.

Hydrocephalus with Hirschsprung disease: severe end of X-linked hydrocephalus spectrum

Takenouchi T, Nakazawa M, Kanemura Y, Shimozato S, Yamasaki M, Takahashi T, Kosaki K.

Am J Med Genet A. 2012 Apr;158A(4):812-5. doi: 10.1002/ajmg.a.35245. Epub 2012 Feb 21.

[New knowledge of spasticity and its treatment]

Lorentzen J, Willerslev-Olsen M, Crone C, Sinkjær T, Nielsen JB.

Ugeskr Laeger. 2012 Feb 27;174(9):569-73.

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.

Intensive aerobic cycling training with lower limb weights in Chinese patients with chronic stroke: discordance between improved cardiovascular fitness and walking ability

Jin H, Jiang Y, Wei Q, Wang B, Ma G.

Disabil Rehabil. 2012;34(19):1665-71. doi: 10.3109/09638288.2012.658952. Epub 2012 Mar 1.

Pilot comparative study of unilateral and bilateral robot-assisted training on upper-extremity performance in patients with stroke

Yang CL, Lin KC, Chen HC, Wu CY, Chen CL.

Am J Occup Ther. 2012 Mar-Apr;66(2):198-206. doi: 10.5014/ajot.2012.003103.

Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post-stroke patients: a proof-of-principle study

Noma T, Matsumoto S, Shimodozono M, Etoh S, Kawahira K.

J Rehabil Med. 2012 Apr;44(4):325-30. doi: 10.2340/16501977-0946.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias